ABEO
ABEONA THERAPEUTICS INC.
NASDAQ · Healthcare · Biotechnology · US
$4.35
−4.61%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- -0.28x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.28x
- Net debt / EBITDA
- 0.51x
Liquidity & coverage
- Current ratio
- 6.63x
- Quick ratio
- 6.40x
- Cash ratio
- 5.92x
- Interest coverage
- -25.25x
- EBITDA / interest
- -21.54x
- Working capital
- $139.8M
Cash & dividend
- FCF / debt
- -4.10x
- Cash flow / debt
- -3.85x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026